ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,201.60
1.67%
S&P ASX All Technology
3,829.30
1.67%
Brent Oil
72.235
-0.66%
US Dollar vs AUD
1.60435
0.31%
Bitcoin
94,922.53
-0.20%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSXV

  6. Pascal Biosciences Inc (PAS) Share Price

Pascal Biosciences Inc

Pascal Biosciences Inc (PAS)

TSXV
0.015
0.00
(0.00%)
Closed 24 December 8:00AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.015
Bid
0.03
Offer
0.03
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
572.1k
Previous Close
0.015
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
38,140,000
Dividend Yield
-
PE Ratio
-0.95
Earnings Per Share (EPS)
-0.01
Revenue
672k
Net Profit
-400k

About Pascal Biosciences Inc

Sector
Blank Checks
Industry
Pharmaceutical Preparations
Website
www.nevisbrands.com
Headquarters
Seattle, Washington, USA
Founded
2011
Pascal Biosciences Inc is listed in the Blank Checks sector of the TSX Venture Exchange with ticker PAS. The last closing price for Pascal Biosciences was $0.02. Over the last year, Pascal Biosciences shares have traded in a share price range of $ 0.00 to $ 0.00.

Pascal Biosciences currently has 38,140,000 shares in issue. The market capitalisation of Pascal Biosciences is $572,100 . Pascal Biosciences has a price to earnings ratio (PE ratio) of -0.95.

Ask ADVFN Intelligence (AI)

PAS Latest News

More News

TSX Venture Exchange Stock Maintenance Bulletins

TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC, May 18, 2023 VANCOUVER, BC, May 18, 2023 /CNW/ - TSX VENTURE COMPANIES ARGO OPPORTUNITY...

19 May 2023
PR Newswire (Canada)

Suspension de la négociation par l'OCRCVM - PAS

Suspension de la négociation par l'OCRCVM - PAS Canada NewsWire VANCOUVER, BC, le 5 déc. 2022 VANCOUVER, BC, le 5 déc. 2022 /CNW/ - L'OCRCVM a suspendu la négociation des titres...

06 December 2022
PR Newswire (Canada)

IIROC Trading Halt - PAS

IIROC Trading Halt - PAS Canada NewsWire VANCOUVER, BC, Dec. 5, 2022 VANCOUVER, BC, Dec. 5, 2022 /CNW/ - The following issues have been halted by IIROC: Company: Pascal Biosciences...

06 December 2022
PR Newswire (Canada)

UPDATE - InvestmentPitch Media Video Discusses Pascal Biosciences and its Non-Brokered Private Placement to Raise up to $900,000 with $0.10 Units – Video Available on Investmentpitch.com

VANCOUVER, British Columbia, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Pascal Biosciences (TSXV:PAS) (OTCPink:PSCBF) (FSE:6PB), a biotechnology company targeting innovative therapies for serious...

04 November 2021
GlobeNewswire Inc.

InvestmentPitch Media Video Discusses Pascal Biosciences and its Award of a National Cancer Institute Grant for its Acute Lymphoblastic Leukemia Program – Video Available on Investmentpitch.com

VANCOUVER, British Columbia, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Pascal Biosciences (TSXV:PAS) (OTCPink:PSCBF) (FSE:6PB), a biotechnology company targeting innovative therapies for serious...

04 November 2021
GlobeNewswire Inc.

SōRSE Technology Partners with & Acquires Part of Cancer Research Group Pascal Biosciences for Cannabinoid Research Programs

Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal”) has entered into a Term Sheet with SōRSE Technology (“SōRSE”) to develop Pascal’s cannabinoid programs. Investing in and financially supporting...

11 March 2020
Business Wire

PASCAL BIOSCIENCES ANNOUNCES PRIVATE PLACEMENT AND POTENTIAL TRANSACTION WITH SŌRSE TECHNOLOGY FOR CANNABINOID RESEARCH PROG...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 10, 2020 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:...

10 March 2020
GlobeNewswire Inc.

Pascal Biosciences and Y-Biologics Announce Research Collaboration for Development of a Bispecific Antibody for Leukemia

VANCOUVER, British Columbia and SEATTLE and DAEJON, Korea, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal”) and Y-Biologics (together the “Companies”) today...

29 October 2019
GlobeNewswire Inc.

Pascal Biosciences Discovers Cannabinoids Activate the Major Histocompatibility Complex to Aid Cancer Treatment

VANCOUVER, British Columbia, and SEATTLE, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”) today revealed the mechanism whereby cannabinoids may...

23 September 2019
GlobeNewswire Inc.

Pascal Biosciences to Present at International Cannabinoid Derived Pharmaceuticals Summit

VANCOUVER, British Columbia and SEATTLE, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”). Pascal announces that Dr. Patrick Gray, CEO, will...

11 September 2019
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

PAS - Frequently Asked Questions (FAQ)

What is the current Pascal Biosciences share price?
The current share price of Pascal Biosciences is $ 0.015
How many Pascal Biosciences shares are in issue?
Pascal Biosciences has 38,140,000 shares in issue
What is the market cap of Pascal Biosciences?
The market capitalisation of Pascal Biosciences is CAD 572.1k
What is the 1 year trading range for Pascal Biosciences share price?
Pascal Biosciences has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Pascal Biosciences?
The price to earnings ratio of Pascal Biosciences is -0.95
What is the cash to sales ratio of Pascal Biosciences?
The cash to sales ratio of Pascal Biosciences is 0.57
What is the reporting currency for Pascal Biosciences?
Pascal Biosciences reports financial results in CAD
What is the latest annual turnover for Pascal Biosciences?
The latest annual turnover of Pascal Biosciences is CAD 672k
What is the latest annual profit for Pascal Biosciences?
The latest annual profit of Pascal Biosciences is CAD -400k
What is the registered address of Pascal Biosciences?
The registered address for Pascal Biosciences is 1900 AIRPORT WAY S, SUITE 201, SEATTLE, WASHINGTON, 98134
What is the Pascal Biosciences website address?
The website address for Pascal Biosciences is www.nevisbrands.com
Which industry sector does Pascal Biosciences operate in?
Pascal Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.04
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.30
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.04
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.30
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.04
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.30
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0

Discussion

View Full Feed
Kgeo Kgeo 3 minutes ago
We've been diluted to hell and back since that 12 number was thrown out tho so not sure it's valid. 

And as a "true" long, I will sell a bunch before it reaches 20, assuming we get approval.  And assuming no reverse split. 

Time will tell, and based on history, lots of
NWBO
Bubae Bubae 3 minutes ago
It isn't exactly unusual for a company in litigation for a breach of contract to arrive at a point where they need to determine the value of their assets. Determining a value for method patents that are currently not commercially viable or with an earnings history would be pretty speculative. That B
BEGI
AveragePenny AveragePenny 3 minutes ago
$HHSE Best-Selling Author Barr McClellan Reveals Campaign Insights and Strategies for Trump Victory in 2024 Election

https://www.einpresswire.com/article/771257686/best-selling-author-barr-mcclellan-reveals-campaign-insights-and-strategies-for-trump-victory-in-2024-election
HHSE
jimr1717 jimr1717 4 minutes ago
An unlimited growing amount.
ILLR
x993231 x993231 4 minutes ago
Additional information will be available on the website prior to the call.   Hmmmmmmm

Website counter.

Thursday after market hours.

X
LWLG
crescentmotor crescentmotor 4 minutes ago
Apparently all the analysts are already on their Christmas break.

As I previously posted, today was a horrible time to schedule a corporate update. That said, the news of the MAA acceptance is great news and somewhat of a de-risking event for AVXL stock. Now we wait for the peer rev
AVXL
glenn1919 glenn1919 4 minutes ago
PRZO.....................https://stockcharts.com/h-sc/ui?s=PRZO&p=W&b=5&g=0&id=p86431144783
PRZO
Debunkinator Debunkinator 4 minutes ago
For sure--Nice little X-Mas tweet with some scoop in it would be just fine with me. 🎅🎁
ASII
Stinger2014 Stinger2014 5 minutes ago
Great insite. And Kaboomracks has it all. Can’t wait till we here and see more about Kaboom 💥
CGAC
stevhoff stevhoff 5 minutes ago
CYN : Somebody explain this one to me:
MENLO PARK, Calif., Dec. 20, 2024 /PRNewswire/ -- Cyngn Inc. (the "Company" or "Cyngn") (Nasdaq: CYN), a developer of AI-powered autonomous driving software solutions for industrial applications, today announced the pricing of a follow on offering, price
poguemahone poguemahone 5 minutes ago
Clocking in at 12 minutes!! 2 minutes of that were Clint & Tom bumbling and fumbling. Is Tom still using a Commodore 64? He never properly turns his mic on when asking questions.

That was one lousy CC.
AVXL
RMS555 RMS555 5 minutes ago
Exactly!!!!!!

Also, Let These Recent & Easily Verifiable Facts of KEGS Sink in:
KEGS was profitable in the 2nd & 3rd Quarter of 2024.
KEGS has verifiable assets, 4 properties in New York.
KEGS is now delivering beer to 45 states plus DC.
KEGS beer is a
KEGS
glenn1919 glenn1919 6 minutes ago
GTBP................................................p/m
GTBP
Ask$lapper Ask$lapper 6 minutes ago
GM LD!!
green maschine green maschine 6 minutes ago
Yep: “We look forward to working closely with the FDA throughout the review period in advance of the August 15, 2025, PDUFA goal date,” said Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals.
TNXP
I am done I am done 7 minutes ago
$HHSE Best-Selling Author Barr McClellan Reveals Campaign Insights and Strategies for Trump Victory in 2024 Presidential Elections
https://www.einpresswire.com/article/771257686/best-selling-author-barr-mcclellan-reveals-campaign-insights-and-strategies-for-trump-victory-in-2024-election
HHSE
mikepgator mikepgator 7 minutes ago
Full Release:

Vivos Inc. Announces Launch of Groundbreaking RadioGel® Precision Radionuclide Therapy™ Human Clinical Trial
December 23, 2024 08:30 ET
| Source: Vivos Inc.


Richland, WA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- – Vivos Inc. (OTCQB: RDGL) p
RDGL
Amigo Mike Amigo Mike 7 minutes ago
Can someone take the post I am replying too and repost it exactly as it is to this board ? Just a copy/paste/post please.

I'd like to "pin" it to the top but cannot pin more than 1 post per user.

Thanks !
ZIVO
Golden Cross Golden Cross 7 minutes ago
$LITM Snow Lake fully funded for 2025 exploration programs on its two uranium projects!
https://finance.yahoo.com/news/snow-lake-provides-corporate-163700991.html
LITM
I am done I am done 7 minutes ago
$HHSE Best-Selling Author Barr McClellan Reveals Campaign Insights and Strategies for Trump Victory in 2024 Presidential Elections
https://www.einpresswire.com/article/771257686/best-selling-author-barr-mcclellan-reveals-campaign-insights-and-strategies-for-trump-victory-in-2024-election
HHSE
RKhan2011 RKhan2011 7 minutes ago
I tink $IGPK > JFHE will pull a $HKD (AMTD Digital Inc) ma fella $JFHE nigggaz PUT IN A sell order at $1 (atleast) for some of yo shares. bwhahahaha NFA just my humble opinion. Lessssss goooooo 😎🤷🏾‍♂️🌙🚀💰🤑

Y'all remember HKD right
HKD IGPK JFHE
tredenwater2 tredenwater2 8 minutes ago
Very anticlimactic CC with lityle to no wuestions but excellent news this year right before Christmas!

On the 210 days for review by the EMA, is this calendar or actual working days with no clock stoppages?

TIA
AVXL
Paulie Pennies Paulie Pennies 8 minutes ago
Could be a great week we got all day today half tomorrow and then all Thursday and Friday big things coming here patience pays 😎
ASII

Your Recent History

TSXV
PAS
Pascal Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads